Bwx Technologies Inc. logo

Bwx Technologies Inc. (BWXT)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
175. 03
-8.35
-4.55%
$
16.28B Market Cap
32.52 P/E Ratio
0.96% Div Yield
1,527,023 Volume
2.94 Eps
$ 183.38
Previous Close
Day Range
174.12 183.57
Year Range
84.21 218.5
Want to track BWXT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days

Summary

BWXT closed yesterday lower at $175.03, a decrease of 4.55% from Thursday's close, completing a monthly decrease of -0.84% or $1.49. Over the past 12 months, BWXT stock gained 56.25%.
BWXT pays dividends to its shareholders, with the most recent payment made on Dec 10, 2025. The next estimated payment will be in In 2 months on Mar 10, 2026 for a total of $0.25.
The last earnings report, released on Nov 04, 2025, exceeded the consensus estimates by 0.14%. On average, the company has fell short of earnings expectations by -0.16%, based on the last three reports. The next scheduled earnings report is due on Feb 23, 2026.
Bwx Technologies Inc. has completed 1 stock splits, with the recent split occurring on Jul 01, 2015.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BWXT Chart

Similar

DHR
Danaher Corporation
$ 226.71
-2.44%
BA
The Boeing Company
$ 204.29
+1.78%
UNP
Union Pacific Corporation
$ 239.94
+1.62%
ETN
Eaton Corporation plc
$ 331.79
-5.3%
DE
Deere & Company
$ 485.24
+1.95%
Two Stocks for a Bullish 2026

Two Stocks for a Bullish 2026

Don't Be Afraid of Mid-Term Years Chances are you've heard – and maybe even believed – the old claim that we only use 10% of our brains. It's catchy.

Investorplace | 5 hours ago
BWX Technologies: Q3 Execution Highlights Strategic Pivot Beyond Defense

BWX Technologies: Q3 Execution Highlights Strategic Pivot Beyond Defense

BWX Technologies delivered a strong Q3, beating expectations and raising FY25 guidance, driven by robust demand and successful Kinectrics integration. BWXT's $7.4B backlog, major NNSA contracts, and growing civilian segment support income diversification justify its premium valuation. Despite higher debt post-Kinectrics, BWXT maintains solid cash flow, but near-term shareholder payouts will remain limited as debt reduction is prioritized.

Seekingalpha | 2 weeks ago
Buy 5 Non-Tech Giants That Have Surged on AI Data Center Boom for 2026

Buy 5 Non-Tech Giants That Have Surged on AI Data Center Boom for 2026

FIX, VRT, MIR, BWXT and EME have surged in 2025 and are set to gain further from the accelerating AI-fueled data center boom in 2026.

Zacks | 3 weeks ago

Bwx Technologies Inc. (BWXT) FAQ

What is the stock price today?

The current price is $175.03.

On which exchange is it traded?

Bwx Technologies Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is BWXT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.96%.

What is its market cap?

As of today, the market cap is 16.28B.

What is the earnings per share?

The EPS is 0.91.

When is the next earnings date?

The next earnings report will release on Feb 23, 2026.

Has Bwx Technologies Inc. ever had a stock split?

Bwx Technologies Inc. had 1 splits and the recent split was on Jul 01, 2015.

Bwx Technologies Inc. Profile

Aerospace & Defense Industry
Industrials Sector
Rex D. Geveden CEO
NYSE Exchange
05605H100 CUSIP
US Country
8,700 Employees
19 Nov 2025 Last Dividend
1 Jul 2015 Last Split
2 Aug 2010 IPO Date

Overview

BWX Technologies, Inc., a prominent company in the nuclear industry, operates on a global scale with its base in Lynchburg, Virginia. Initially known as The Babcock & Wilcox Company, it underwent a rebranding to BWX Technologies, Inc. in June 2015. Founded in 1867, the company has built a solid reputation for manufacturing and selling nuclear components, with its operations branching into the United States, Canada, and other international markets. BWX Technologies divides its operations into two main segments: Government Operations and Commercial Operations, catering to a diverse clientele that includes naval and commercial shipping customers, along with colleges, universities, and national laboratories. This strategic segmentation allows BWX Technologies to leverage its expertise in naval nuclear components, reactors, nuclear fuel, and a range of other nuclear-related services and products.

Products and Services

  • Naval Nuclear Components and Reactors
  • This involves the design and manufacture of critical components for naval nuclear reactors, including reactors themselves and nuclear fuel, to support the navy's fleet.

  • Nuclear Fuel Services
  • The company is also engaged in the down-blending of government stockpiles of uranium, handling, storing, characterizing, dissolving, recovering, and purifying uranium-bearing materials. Additionally, it supplies research reactor fuel elements to academic and national research facilities.

  • Commercial Nuclear Components
  • In the commercial sector, BWXT manufactures steam generators, heat exchangers, pressure vessels, and various reactor components essential for nuclear power plants. This extends to auxiliary equipment such as storage containers for nuclear fuel and high-level nuclear waste.

  • Maintenance and Inspection Services
  • BWX Technologies offers comprehensive in-plant inspection, maintenance, and modification services, alongside non-destructive examination and tooling/repair solutions, supporting the ongoing operation and safety of nuclear facilities.

  • CANDU Nuclear Power Plant Products and Services
  • The company provides nuclear fuel, fuel handling systems, tooling delivery systems, nuclear grade materials, and precisely machined components, along with related services, tailored for CANDU reactors, a type of nuclear reactor developed by Canada.

  • Medical Isotopes and Radiopharmaceuticals Manufacturing
  • On the cutting edge of nuclear medicine, BWX Technologies ventures into the health sector by manufacturing medical radioisotopes and radiopharmaceuticals for diagnostic and therapeutic purposes, in addition to medical devices.

Contact Information

Address: 800 Main Street
Phone: 434 522 3800